Full steam ahead at OARSI 2025
🌍 ENDOTARGET at the OARSI World Congress 2025
📍 Incheon, South Korea | April 2025
The ENDOTARGET project was proud to be part of this year’s OARSI World Congress, the leading global forum for osteoarthritis research and innovation. Representing Europe in an international community of scientists, clinicians, and innovators, three of our consortium partners showcased the latest findings from ENDOTARGET’s work on chronic inflammation, gut-joint axis, and systemic endotoxemia.
Four poster presentations highlighted our multidisciplinary research:
🧪 ETH Zurich
“Chronic lipopolysaccharide exposure induces sex-dependent low-grade inflammation but does not initiate osteoarthritis in rats”
🔍 Helsinki University Hospital (HUS)
“Complementing Traditional Histopathology: Cartilage roughness score 2D (CRS2D) as an Efficient Tool for Detecting Subtle Surface Changes in Osteoarthritis” &
“Wistar and Sprague-Dawley rats revealed microbial differences potentially linked to joint damage”
💡 TU Wien
“Human Synovial Biochips for OA and RA research using pneumatic actuation for tissue-authentic maturation to evaluate LPS-induced inflammatory potential”
These contributions underline ENDOTARGET’s mission to uncover novel mechanisms linking gut health and joint disease, and to develop personalised strategies for early detection, prevention, and treatment.
👏 A huge thank you to our researchers for bringing ENDOTARGET to the global stage!
